The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste.
Saved in:
| Title: | The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste. |
|---|---|
| Authors: | Donners AAMT; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van der Zwet K; Van Creveldkliniek, Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Rademaker CMA; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Egberts TCG; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands., Schutgens REG; Van Creveldkliniek, Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Fischer K; Van Creveldkliniek, Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. |
| Source: | Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2023 Feb 08; Vol. 7 (2), pp. 100074. Date of Electronic Publication: 2023 Feb 08 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101703775 Publication Model: eCollection Cited Medium: Internet ISSN: 2475-0379 (Electronic) Linking ISSN: 24750379 NLM ISO Abbreviation: Res Pract Thromb Haemost Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36915864 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Donners+AAMT%22">Donners AAMT</searchLink>; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Zwet+K%22">van der Zwet K</searchLink>; Van Creveldkliniek, Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rademaker+CMA%22">Rademaker CMA</searchLink>; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Egberts+TCG%22">Egberts TCG</searchLink>; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schutgens+REG%22">Schutgens REG</searchLink>; Van Creveldkliniek, Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Fischer+K%22">Fischer K</searchLink>; Van Creveldkliniek, Center for Benign Haematology, Thrombosis and Haemostasis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101703775%22">Research and practice in thrombosis and haemostasis</searchLink> [Res Pract Thromb Haemost] 2023 Feb 08; Vol. 7 (2), pp. 100074. <i>Date of Electronic Publication: </i>2023 Feb 08 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101703775 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2475-0379 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224750379%22">24750379 </searchLink><i>NLM ISO Abbreviation: </i>Res Pract Thromb Haemost <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36915864 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.rpth.2023.100074 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100074 Titles: – TitleFull: The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Donners AAMT – PersonEntity: Name: NameFull: van der Zwet K – PersonEntity: Name: NameFull: Rademaker CMA – PersonEntity: Name: NameFull: Egberts TCG – PersonEntity: Name: NameFull: Schutgens REG – PersonEntity: Name: NameFull: Fischer K IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 02 Text: 2023 Feb 08 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2475-0379 Numbering: – Type: volume Value: 7 – Type: issue Value: 2 Titles: – TitleFull: Research and practice in thrombosis and haemostasis Type: main |
| ResultId | 1 |
